Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44
Reuters2026/09/01 21:19- Nurix Therapeutics Chief Scientific Officer Gwenn Hansen exercised employee stock options for 1,452 shares at USD 1.86 on Sept. 1, 2026.
- Hansen sold 1,452 shares at USD 25.47 the same day.
- Directly held common stock ended at 117,227 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British banks "offload risk" for cash: high-risk retail loan collateral surges twofold in a single week
According to disclosure documents from the Bank of England, British commercial banks are increasingly using high-risk assets—such as loans related to high-interest department store credit cards and car leasing—as collateral pledged to the Bank of England.
NEC, Mitsubishi Heavy sign MOU for strategic defense partnership
Umida expands Joluca Elektrolytes tie-up with Apoteket AB to at least 140 stores
Sanlorenzo to attend UBS Luxury Conference 2026, meets investors
Crypto prices
More
